Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-16

FDA Approved: CHILDRENS IBUPROFEN — Supplemental Application (Better Living Brands, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Children's Ibuprofen (ibuprofen) from Better Living Brands, LLC, indicating changes to the approved labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS IBUPROFEN (IBUPROFEN)

Snippet

SUPPL AP for CHILDRENS IBUPROFEN (IBUPROFEN)